ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Louisville, KY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Nasal Polyps
Allergic Rhinitis
Rhinitis
Rhinosinusitis
Sinusitis
Respiration Disorders

Asthma trials near Louisville, KY, USA:

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations....

Enrolling
Asthma
Drug: Placebo
Drug: Rocatinlimab

Phase 2

Amgen
Amgen

Louisville, Kentucky, United States and 137 other locations

The purpose of this study is to assess the PD equivalence of the approved asthma combination therapy, BDA, delivered using the proposed repl....

Enrolling
Asthma
Drug: BDA MDI HFO 160/180 μg
Drug: BDA MDI HFA 160/180 μg

Phase 3

AstraZeneca
AstraZeneca

Louisville, Kentucky, United States and 134 other locations

Locations recently updated

This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condi...

Enrolling
Asthma
Drug: dupilumab
Drug: Matching Placebo

Phase 4

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Louisville, Kentucky, United States and 47 other locations

and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...

Enrolling
Asthma
Drug: Placebo
Drug: Atuliflapon

Phase 2

AstraZeneca
AstraZeneca

Louisville, Kentucky, United States and 382 other locations

variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...

Active, not recruiting
Asthma
Drug: BFF pMDI 320/9 μg
Drug: BFF MDI 320/9.6 μg

Phase 3

AstraZeneca
AstraZeneca

Louisville, Kentucky, United States and 361 other locations

MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis...

Enrolling
Asthma
Combination Product: BDA MDI
Combination Product: AS MDI

Phase 3

AstraZeneca
AstraZeneca

Louisville, Kentucky, United States and 106 other locations

The primary purpose of this study is to evaluate the effects of Fluticasone Furoate (FF)/ Umeclidinium (UMEC)/ Vilanterol (VI) on lung function compa...

Enrolling
Asthma
Drug: FF/VI
Device: ELLIPTA

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Louisville, Kentucky, United States and 79 other locations

inhaler (MDI) containing propellant 1,1-difluoroethane (HFA-152a) or 1,1,1,2-tetrafluoroethane (HFA-134a) in participants aged \>=18 years with asthma...

Enrolling
Asthma
Drug: Salbutamol HFA-152a
Drug: Salbutamol HFA-134a

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Louisville, Kentucky, United States and 100 other locations

decline in adult patients with uncontrolled moderate to severe asthma.The estimated duration is 4±1 weeks of screening and run-in period, fo...

Enrolling
Asthma
Drug: Placebo
Drug: Dupilumab

Phase 4

Sanofi
Sanofi

Louisville, Kentucky, United States and 242 other locations

This is a randomized, double-blind, placebo-controlled, parallel-group, international, multicenter, Phase 3 study to evaluate the efficacy and safety...

Active, not recruiting
Nasal Polyposis
Biological: Matched placebo
Biological: Benralizumab 30 mg

Phase 3

AstraZeneca
AstraZeneca

Louisville, Kentucky, United States and 115 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems